In VAP different dosage group, MMP-13, ADAMTS-4 and ADAMTS-5 mRNA expression decrease moderately, P < 0.05, data was statistically significant,but there was no significant difference between three different dosages of treatment groups (Fig. 2g). The gene discussed is ADAMTS5; the disease is ventilator-associated pneumonia.